Published On: Wed, Oct 19th, 2016

LifePoint Hospitals, Inc. (NASDAQ:LPNT) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of LifePoint Hospitals, Inc. (NASDAQ:LPNT).

Most recent broker ratings

08/01/2016 – LifePoint Hospitals, Inc. had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 66 price target on the stock.

08/01/2016 – LifePoint Hospitals, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 77 price target on the stock.

08/01/2016 – LifePoint Hospitals, Inc. had its “neutral” rating reiterated by analysts at Mizuho. They now have a USD 56 price target on the stock.

06/06/2016 – LifePoint Hospitals, Inc. had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 82 price target on the stock.

05/02/2016 – LifePoint Hospitals, Inc. had its “underweight” rating reiterated by analysts at Barclays. They now have a USD 70 price target on the stock.

02/19/2016 – LifePoint Hospitals, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 77 price target on the stock.

02/17/2016 – LifePoint Hospitals, Inc. had its “outperform” rating reiterated by analysts at Robert W. Baird. They now have a USD 74 price target on the stock.

02/16/2016 – LifePoint Hospitals, Inc. had its “market outperform” rating reiterated by analysts at Avondale Partners. They now have a USD 88 price target on the stock.

01/06/2016 – LifePoint Hospitals, Inc. was upgraded to “outperform” by analysts at Raymond James. They now have a USD 85 price target on the stock.

12/16/2015 – Credit Suisse began new coverage on LifePoint Hospitals, Inc. giving the company a “outperform” rating. They now have a USD 79 price target on the stock.

11/04/2015 – LifePoint Hospitals, Inc. had its “hold” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 75 price target on the stock.

11/02/2015 – LifePoint Hospitals, Inc. had its “market perform” rating reiterated by analysts at Oppenheimer.

11/02/2015 – LifePoint Hospitals, Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 82 price target on the stock.

10/19/2015 – LifePoint Hospitals, Inc. had its “neutral” rating reiterated by analysts at Susquehanna. They now have a USD 75 price target on the stock.

09/16/2015 – JP Morgan began new coverage on LifePoint Hospitals, Inc. giving the company a “neutral” rating. They now have a USD 79 price target on the stock.

The share price of LifePoint Hospitals, Inc. (NASDAQ:LPNT) was up +2.24% during the last day of trading, with a day high of 62.10. 386120 shares were traded during the last session.

The stock’s 50 day moving average is 58.59 and its 200 day moving average is 63.59. The stock’s market capitalization is 2.63B. LifePoint Hospitals, Inc. has a 52-week low of 54.82 and a 52-week high of 75.94.

LifePoint Health, Inc., formerly LifePoint Hospitals, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds. It offers patient services at its facilities. It hospitals provide a range of medical and surgical services in hospitals in non-urban markets. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.